TESTING POTENTIAL GYRASE INHIBITORS OF BACTERIAL-DNA GYRASE - A COMPARISON OF THE SUPERCOILING INHIBITION ASSAY AND CLEAVABLE COMPLEX ASSAY

被引:28
作者
BARRETT, JF
BERNSTEIN, JI
KRAUSE, HM
HILLIARD, JJ
OHEMENG, KA
机构
[1] The R. W. Johnson Pharmaceutical Research Institute, Raritan, NJ 08869-0602, Microbiology Discovery B-208, 1000 Route 202
关键词
D O I
10.1006/abio.1993.1493
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Inhibitory activity of test compounds against Escherichia coli DNA gyrase in a "cleavable complex" assay, readily observed in vitro at the enzyme level by the artificial addition of a denaturing agent, is found to be an excellent indicator of 4-quinolone inhibition of DNA gyrase, and as accurate a predictor of target enzyme inhibitory activity as the measurement of the inhibition of DNA gyrase supercoiling. This study was designed to examine the specificity of DNA gyrase inhibitors of various chemical classes in these two DNA gyrase assays, and define the use of these two assays in understanding the nature of inhibition by experimental compounds. Supercoiling inhibition was detected by determination of the 50% inhibition level, and cleavable complex inhibition measured by the determination of the drug concentration at which 50% of the maximal (of control) formation of linear, cleaved DNA was obtained. Results indicate that these two assays can serve several different functions in microbiological research, among them: (1) quantitation of enzyme inhibitory activity at the target level; and (2) distinguishing between nonspecific inhibition or artifactual inhibition of DNA gyrase and true, mechanism-based inhibition of the catalytic activity of DNA gyrase. © 1993 Academic Press, Inc.
引用
收藏
页码:313 / 317
页数:5
相关论文
共 18 条
[1]   USE OF INVITRO TOPOISOMERASE-II ASSAYS FOR STUDYING QUINOLONE ANTIBACTERIAL AGENTS [J].
BARRETT, JF ;
GOOTZ, TD ;
MCGUIRK, PR ;
FARRELL, CA ;
SOKOLOWSKI, SA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) :1697-1703
[2]   LOCAL SEQUENCE REQUIREMENTS FOR DNA CLEAVAGE BY MAMMALIAN TOPOISOMERASE-II IN THE PRESENCE OF DOXORUBICIN [J].
CAPRANICO, G ;
KOHN, KW ;
POMMIER, Y .
NUCLEIC ACIDS RESEARCH, 1990, 18 (22) :6611-6619
[3]  
DENNY WA, 1989, ANTI-CANCER DRUG DES, V4, P241
[4]   NEW STRUCTURE-ACTIVITY-RELATIONSHIPS OF THE QUINOLONE ANTIBACTERIALS USING THE TARGET ENZYME - THE DEVELOPMENT AND APPLICATION OF A DNA GYRASE ASSAY [J].
DOMAGALA, JM ;
HANNA, LD ;
HEIFETZ, CL ;
HUTT, MP ;
MICH, TF ;
SANCHEZ, JP ;
SOLOMON, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (03) :394-404
[5]   INHIBITORS OF DNA TOPOISOMERASES [J].
DRLICA, K ;
FRANCO, RJ .
BIOCHEMISTRY, 1988, 27 (07) :2253-2259
[6]   NEWLY DOCUMENTED ANTIMICROBIAL ACTIVITY OF QUINOLONES [J].
FURET, YX ;
PECHERE, JC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (04) :249-254
[7]   NOVOBIOCIN AND COUMERMYCIN INHIBIT DNA SUPERCOILING CATALYZED BY DNA GYRASE [J].
GELLERT, M ;
ODEA, MH ;
ITOH, T ;
TOMIZAWA, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (12) :4474-4478
[8]   INHIBITORY EFFECTS OF QUINOLONES ON DNA GYRASE OF ESCHERICHIA-COLI AND TOPOISOMERASE-II OF FETAL CALF THYMUS [J].
HOSHINO, K ;
SATO, K ;
UNE, T ;
OSADA, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) :1816-1818
[9]  
MADOFF S, 1988, REV INFECT DIS, V10, P602
[10]   THE MOLECULAR-BASIS OF QUINOLONE ACTION [J].
MAXWELL, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (04) :409-414